Der Schmerz
-
The paper reports the results of a population-based pain survey in Lübeck, a city of 210,000 inhabitants in the northern part of Germany. Data were collected from 308 respondents (systematic sample aged 26-75 years) by mailed questionnaires (response rate: 80%). Subjects indicated on a list of 11 pain conditions whether they suffered from these kinds of painever, during the past 6 months, or "today". ⋯ However, 8% of the total sample reported more than 14 pain-related disability days and were classified as being affected by pain to a sociomedically relevant degree. Approximately half of the subjects who reported pain in the past 6 months did not consult a physician. This proportion decreased considerably in subgroups with more than 6 disability days.
-
Oral baclofen, the most often prescribed antispastic drug, has been shown to be effective in trigeminal neuralgia. Spinal application of baclofen leads to a complete supression of spasticity even in cases in which no previous oral antispastic medication achieved a response. ⋯ Spinal baclofen has also been effective during long-term infusion with an implanted pump for more than 1 year. Spinal baclofen infusion seems to be a possibility in the treatment of severe trigeminal neuralgia resistant to other forms of therapy.